BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 29943384)

  • 1. The efficacy of vaginal suppository based on myrtle in patients with cervicovaginal human papillomavirus infection: A randomized, double-blind, placebo trial.
    Nikakhtar Z; Hasanzadeh M; Hamedi SS; Najafi MN; Tavassoli AP; Feyzabadi Z; Meshkat Z; Saki A
    Phytother Res; 2018 Oct; 32(10):2002-2008. PubMed ID: 29943384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a novel herbal vaginal suppository containing myrtle and oak gall in the treatment of vaginitis: a randomized clinical trial.
    Askari SF; Jahromi BN; Dehghanian A; Zarei A; Tansaz M; Badr P; Azadi A; Mohagheghzadeh A
    Daru; 2020 Dec; 28(2):603-614. PubMed ID: 32888185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.
    Holmes MM; Weaver SH; Vermillion ST
    Infect Dis Obstet Gynecol; 1999; 7(4):186-9. PubMed ID: 10449266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of myrtle fruit syrup on abnormal uterine bleeding: a randomized double-blind, placebo-controlled pilot study.
    Qaraaty M; Kamali SH; Dabaghian FH; Zafarghandi N; Mokaberinejad R; Mobli M; Amin G; Naseri M; Kamalinejad M; Amin M; Ghaseminejad A; HosseiniKhabiri SJ; Talei D
    Daru; 2014 Jun; 22(1):45. PubMed ID: 24888316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myrtle (Myrtus communis L.) fruit syrup for gastroesophageal reflux disease in children: A double-blind randomized clinical trial.
    Paknejad MS; Eftekhari K; Rahimi R; Vigeh M; Naghizadeh A; Karimi M
    Phytother Res; 2021 Nov; 35(11):6369-6376. PubMed ID: 34533246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myrtus communis L. Freeze-Dried Aqueous Extract Versus Omeprazol in Gastrointestinal Reflux Disease: A Double-Blind Randomized Controlled Clinical Trial.
    Zohalinezhad ME; Hosseini-Asl MK; Akrami R; Nimrouzi M; Salehi A; Zarshenas MM
    J Evid Based Complementary Altern Med; 2016 Jan; 21(1):23-9. PubMed ID: 26045552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
    Ramanakumar AV; Naud P; Roteli-Martins CM; de Carvalho NS; de Borba PC; Teixeira JC; Blatter M; Moscicki AB; Harper DM; Romanowski B; Tyring SK; Ramjattan B; Schuind A; Dubin G; Franco EL;
    BMJ Open; 2016 Aug; 6(8):e011371. PubMed ID: 27566633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of a paste containing Myrtus communis (Myrtle) in the management of recurrent aphthous stomatitis: a randomized controlled trial.
    Babaee N; Mansourian A; Momen-Heravi F; Moghadamnia A; Momen-Beitollahi J
    Clin Oral Investig; 2010 Feb; 14(1):65-70. PubMed ID: 19306024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus.
    Polansky H; Itzkovitz E; Javaherian A
    Drug Des Devel Ther; 2017; 11():575-583. PubMed ID: 28424535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Chlorquinaldol-Promestriene Vaginal Tablets and Opin Suppositories Effect on Inflammatory Factors and Immune Function in Chronic HPV Cervicitis.
    Chen X; Guo H
    J Coll Physicians Surg Pak; 2019 Feb; 29(2):115-118. PubMed ID: 30700347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic and therapeutic concepts of HPV infection in HIV-positive women].
    Küppers V; von Eckardstein S; Adomeit A; Wingartz C; Bodden-Heidrich R; Koldovsky U; Bender HG
    Zentralbl Gynakol; 1999; 121(1):27-30. PubMed ID: 10091310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
    Snoeck R; Bossens M; Parent D; Delaere B; Degreef H; Van Ranst M; Noël JC; Wulfsohn MS; Rooney JF; Jaffe HS; De Clercq E
    Clin Infect Dis; 2001 Sep; 33(5):597-602. PubMed ID: 11477525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of postoperative belladonna and opium rectal suppositories in vaginal surgery.
    Butler K; Yi J; Wasson M; Klauschie J; Ryan D; Hentz J; Cornella J; Magtibay P; Kho R
    Am J Obstet Gynecol; 2017 May; 216(5):491.e1-491.e6. PubMed ID: 28040448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.
    Marais D; Gawarecki D; Allan B; Ahmed K; Altini L; Cassim N; Gopolang F; Hoffman M; Ramjee G; Williamson AL
    Antivir Ther; 2011; 16(8):1219-26. PubMed ID: 22155903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of inosine pranobex oral therapy in subclinical human papillomavirus infection of the vulva: a randomized double-blinded placebo controlled study.
    Tay SK
    Int J STD AIDS; 1996 Jul; 7(4):276-80. PubMed ID: 8876359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
    Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
    Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
    Garland SM; Hernandez-Avila M; Wheeler CM; Perez G; Harper DM; Leodolter S; Tang GW; Ferris DG; Steben M; Bryan J; Taddeo FJ; Railkar R; Esser MT; Sings HL; Nelson M; Boslego J; Sattler C; Barr E; Koutsky LA;
    N Engl J Med; 2007 May; 356(19):1928-43. PubMed ID: 17494926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.
    Vandepapeliere P; Barrasso R; Meijer CJ; Walboomers JM; Wettendorff M; Stanberry LR; Lacey CJ
    J Infect Dis; 2005 Dec; 192(12):2099-107. PubMed ID: 16288373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Myrtle (Myrtus communis L.) improved non-specific immune parameters and bactericidal activity of skin mucus in rainbow trout (Oncorhynchus mykiss) fingerlings.
    Mansouri Taee H; Hajimoradloo A; Hoseinifar SH; Ahmadvand H
    Fish Shellfish Immunol; 2017 May; 64():320-324. PubMed ID: 28330807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.